Abbott right now introduced the discharge of a brand new model of its fashionable FreeStyle Libre 2 sensor that may combine with the t:slim X2 insulin pump, forming a “closed loop” automated insulin supply system. For the primary time, insulin pump customers will be capable to use a FreeStyle Libre sensor to mechanically choose and modify insulin doses, increasing the choices for individuals with diabetes to make use of probably the most superior blood sugar administration know-how but developed.
The brand new sensor is called the FreeStyle Libre 2 Plus, and it’s the first sensor from the FreeStyle Libre household of steady glucose displays (CGMs) that’s prepared to be used in a closed-loop system. It may additionally instantly grow to be one of many extra reasonably priced “looping” choices available on the market — Libre CGM sensors are sometimes priced decrease than the choices from competitor Dexcom.
The FreeStyle Libre 2 Plus is a brand new and improved model of Abbott’s fashionable FreeStyle Libre 2 CGM sensor. This sensor mechanically gives a brand new blood glucose measurement each minute (no extra “scanning”) and boasts an industry-leading put on time of 15 days.
Linking up with the Tandem t:slim X2 insulin pump, the brand new “hybrid closed loop system” will make the most of Tandem’s fashionable Management-IQ algorithm, which makes use of blood sugar measurements to foretell how a lot insulin a consumer requires. The Management-IQ system communicates between the CGM sensor and Tandem’s t:slim X2 insulin pump, mechanically deciding when to present kind of insulin with a purpose to preserve a consumer’s blood sugar in a wholesome vary as usually as potential. Management-IQ can modify insulin charges each 5 minutes and droop insulin supply or ship correction boluses to keep away from hypo- and hyperglycemia. (To get the very best outcomes, customers nonetheless have to make handbook changes to insulin supply charges to account for meals and elements similar to train.)
Customers of the FreeStyle Libre 3 system, which has the smallest sensors available on the market, will nonetheless have to attend to sync up their CGM with an insulin pump. An Abbott spokesman may solely verify that the corporate was working with Tandem to combine the Libre 3 with the t:slim X2 “as quickly as potential.”
In a matter of weeks, the looping choices for individuals with diabetes have drastically expanded. Abbott’s largest competitor, Dexcom, just lately introduced that its personal next-gen G7 sensor can now combine with two insulin pumps, the t:slim X2 and the iLet.
Tandem customers will be capable to add FreeStyle Libre 2 Plus sensor integration without spending a dime; all it takes is downloading a software program replace, and all new prospects could have the combination mechanically enabled.
Your native pharmacy, nevertheless, could not have FreeStyle Libre 2 Plus sensors in inventory. Abbott asks potential prospects to name their buyer care group (1-844-330-5535) to obtain a listing of sturdy medical tools (DME) suppliers who could have the brand new sensors in inventory.
